SARS-CoV-2 Omicron Spike RBD Protein Biotinylated

• Description:

  SARS-CoV-2 Omicron Spike RBD Protein Biotinylated_x000D_ Catalog number: B2010591_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: 30 kDa_x000D_ Supplied as: Liquid_x000D_ Applications: molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants_x000D_ Storage: -20C_x000D_ Keywords: SARS-CoV-2 B.1.1.529, Omicron RBD, Omicron Spike_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ Download SARS-CoV-2 Brochure_x000D_ _x000D_ References:_x000D_ 1: Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G,_x000D_ Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M. Evolution patterns of_x000D_ SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun. 2021_x000D_ Jan 29;538:88-91._x000D_ _x000D_ 2: Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on_x000D_ structure, pathogenicity and immunity aspects of pandemic human coronaviruses._x000D_ Infect Genet Evol. 2020 Nov;85:104502._x000D_ _x000D_ 3: Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: Structure,_x000D_ Biology, and Structure-Based Therapeutics Development. Front Cell Infect_x000D_ Microbiol. 2020 Nov 25;10:587269._x000D_ _x000D_ 4: Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and_x000D_ Pathogenesis. Trends Immunol. 2020 Dec;41(12):1100-1115._x000D_ _x000D_ 5: Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat_x000D_ Rev Microbiol. 2021 Mar;19(3):141-154._x000D_ _x000D_ 6: Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, Yahalom-_x000D_ Ronen Y, Tamir H, Achdout H, Stein D, Israeli O, Beth-Din A, Melamed S, Weiss S,_x000D_ Israely T, Paran N, Schwartz M, Stern-Ginossar N. The coding capacity of SARS-_x000D_ CoV-2. Nature. 2021 Jan;589(7840):125-130._x000D_ _x000D_ 7: Bakhiet M, Taurin S. SARS-CoV-2: Targeted managements and vaccine_x000D_ development. Cytokine Growth Factor Rev. 2021 Apr;58:16-29._x000D_ _x000D_ 8: Sanyal S. How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we_x000D_ know so far. Emerg Top Life Sci. 2020 Dec 11;4(4):371-378._x000D_ _x000D_ 9: Campos DMO, Fulco UL, de Oliveira CBS, Oliveira JIN. SARS-CoV-2 virus_x000D_ infection: Targets and antiviral pharmacological strategies. J Evid Based Med._x000D_ 2020 Nov;13(4):255-260._x000D_ _x000D_ 10: Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao_x000D_ Z. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal_x000D_ swabs specimens. J Med Virol. 2020 Sep;92(9):1676-1680. _x000D_ _x000D_ Products Related to SARS-CoV-2 Omicron Spike RBD Protein Biotinylated: Proteins

• Short Description:

  Catalog Number: B2010591 (50 ug)_x000D_ SARS-CoV-2 Omicron Spike RBD Protein Biotinylated is a highly pure biotinylated recombinant SARS-CoV-2 Spike RBD of the Omicron (B.1.1.529) variant. This product has been used as molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants. It has also been used in a wide array of other biochemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5